Genomic Health, Inc. · Redwood City, CA United States (NASDAQ: GHDX)
| 301 Penobscot Dr. | Phone: 650-556-9300 |
| Redwood City, CA | Fax: 650-556-1132 |
| 94063 | |
| United States | 
Map This Company |
Genomic Health, Inc. Rankings
Company Description
Genomic Health believes the genome is key to good health. The company conducts genomic research to develop molecular diagnostics and assays that can predict the likelihood of disease recurrence and response to therapy and treatments. Genomic Health's Oncotype DX breast cancer test predicts the likelihood of chemotherapy effectiveness and cancer recurrence in women with newly diagnosed, early stage invasive breast cancer. Genomic Health's research efforts are targeted at providing a wider base of cancer-related tests, and in 2010 it launched a new Oncotype DX colon cancer test to predict recurrence rates for stage II colon cancer patients. The company sells its products to oncologists and pathologists.
Genomic Health, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: GHDX Single Location |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 472 |
Executives
41 executives listed for Genomic Health, Inc.'s Redwood City, CA location.
| Chairman | Randal Scott | |
|---|---|---|
| President, CEO, and Director | Kimberly Popovits | |
| COO and Secretary | G. Bradley Cole |